Overview
Status
Active
Registry date
2016-04-14
Share capital
100 000,00 PLN
Registered address
ul. Równoległa 8, 42-600 Tarnowskie Góry, Poland
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 34.60kMedianUSD 77.87kAverageUSD 767.93k
Net profit
This companyUSD 27.77kMedianUSD -62.52AverageUSD 27.48k
Operating costs
This companyUSD 4.00kMedianUSD 52.71kAverageUSD 547.01k
Assets
This companyUSD 2.73mMedianUSD 412.41kAverageUSD 4.56m
Industry
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| May 27, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Starosta Tarnogórski |
Tenders
No recorded participation in tenders.
Authorized Representatives
Andrzej Wojciech Głąbicki — President of the Management Board
Manner of representation
The President of the Management Board independently, or the Vice-President of the Management Board independently, or two remaining members of the management board jointly, or a member of the management board jointly with a commercial proxy.
Supervisory board
Bożena Anna Usarek — Supervisory Board Member
Jadwiga Barbara Głąbicka — Supervisory Board Member
Tomasz Ryszard Usarek — Supervisory Board Member
Ownership
| Owner |
|---|
Cindy Nicole Głąbicka (34) |
Beneficial owners
| Person | Rights | |
|---|---|---|
Cindy Głąbicka (34) | Shareholder of a joint-stock company, 100.0% |
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Travel Luxsp. z o.o. | 27,012.43 USD | 100% | ||
Bioxon Pharmasp. z o.o. | 8,103.73 USD | 100% | ||
Red Pharma Healthcaresp. z o.o. | 6,753.11 USD | 50% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Grupa Pek-Linesp. z o.o. | $288,786.80 | pek-line.pl | ||
| Groborz Nieruchomościsp. z o.o. | $61,169.81 | mm-nieruchomosci.com | ||
| Home Centersp. z o.o. | $50,244.49 | homecenter.com.pl | ||
| Investoresp. z o.o. | $46,006.30 | investore.pl | ||
| Ifi-Rsp. z o.o. | $33,633.81 | ifi.com.pl | ||
| ARS Teamsp. z o.o. | $26,572.95 | arsteam.eu | ||
| New-Flatsp. z o.o. | $14,368.92 | new-flat.pl | ||
| ORO Investmentsp. z o.o. | $13,626.52 | oroinvestment.pl | ||
| Finea Inwestsp. z o.o. | $8,538.86 | szanti.pl | ||
| Śląskie KamieniceS.A. | $7,783.81 | slaskiekamienice.pl |
FAQ
The main business activity of Almenia Cin focuses on buying and selling of own real estate.
The company was registered in the Polish National Court Register (KRS) on April 14, 2016.
The headquarters is located at: ul. Równoległa 8, 42-600 Tarnowskie Góry.
The management board consists of: Andrzej Wojciech Głąbicki (President of the Management Board).
The share capital of the company is PLN 100,000 (approx. $27,012).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
In 2024, the company generated total revenue of $34,758, representing a decrease of 73.3% compared to 2023.
Yes, in 2024 the company was profitable, achieving a net profit of $28,398, meaning the company decreased its profit by 75.5%.
The largest operating cost category falls under external services. This category amounted to $3,552 in 2024, representing 100% of all operating expenses.
Last updated: 2026-07-10